human
respiratori
syncyti
viru
rsv
parainfluenza
viru
belong
paramyxovirida
famili
rsv
main
viral
caus
acut
lower
respiratori
tract
ill
effect
antivir
therapi
vaccin
avail
either
viru
rsv
two
main
surfac
envelop
glycoprotein
attach
protein
rsv
g
fusion
protein
f
g
glycoprotein
thought
mediat
viru
attach
cell
receptor
sialic
rsv
g
may
bind
heparan
f
glycoprotein
mediat
least
two
essenti
step
viru
life
cycl
requir
membran
fusion
promot
fusion
viral
cellular
membran
subsequ
transfer
viral
genom
materi
cell
promot
fusion
infect
cell
membran
adjac
cell
membran
lead
syncytia
format
f
glycoprotein
rsv
synthes
inact
precursor
cotransl
modifi
addit
nlink
glycosyl
endoplasm
reticulum
f
precursor
cleav
cellular
trypsinlik
endoproteas
two
disulfidelink
subunit
reach
cell
surfac
assembl
higherord
rsv
infect
cell
vitro
despit
lack
g
indic
f
may
addit
function
attach
host
coreceptor
process
membran
fusion
essenti
entri
cellfre
cellassoci
viru
rsv
share
properti
syncytium
format
phindepend
fusion
without
common
host
determin
may
involv
essenti
process
requir
viral
entri
syncytium
format
fusion
glycoprotein
virus
share
element
similar
function
structur
case
sequenc
indic
common
membran
fusion
particular
paramyxoviru
f
protein
share
conserv
hydrophob
sequenc
amino
termini
import
interact
lipid
bilay
follow
region
heptad
although
much
known
properti
membran
fusion
select
cellular
compart
artifici
lipid
membran
molecular
mechan
virusinduc
cellular
fusion
reaction
remain
mostli
celltocel
fusion
mediat
viral
envelop
protein
involv
cellular
actin
cytoskeleton
cell
surfac
host
cellular
protein
maintain
cell
membran
integr
cell
mobil
rhoa
might
expect
involv
virusinduc
fusion
syncytium
format
howev
direct
evid
present
involv
rhoa
bind
rsv
f
protein
mediat
virusinduc
syncytium
addit
rhoa
amino
acid
bind
rsv
f
amino
acid
rhoa
small
gtpase
ra
superfamili
control
plethora
biolog
function
includ
actin
reorgan
gene
express
cell
morpholog
cell
motil
cell
report
rhoa
peptid
deriv
domain
bind
rsv
f
protein
potent
antivir
activ
rsv
infect
cell
cultur
rsvinfect
mice
data
provid
addit
evid
conserv
structur
function
featur
fusion
protein
rsv
possibl
common
mechan
involv
virusinduc
membran
fusion
inhibitori
effect
peptid
may
use
develop
new
antivir
strategi
broad
applic
effect
rhoa
peptid
rsvinduc
syncytium
synthes
three
overlap
peptid
span
f
bind
domain
rhoa
amino
acid
use
studi
effect
peptid
virusinduc
syncytium
format
pretreat
viru
inoculum
peptid
complet
block
plaqu
format
wherea
pretreat
effect
plaqu
format
rel
mediatr
control
fig
peptid
block
rsvinduc
syncytium
format
vari
concentr
show
concentr
requir
inhibit
number
plaqu
immunoperoxidas
stain
show
rsv
antigenposit
cell
treat
indic
rsv
replic
inhibit
step
viral
protein
synthesi
data
indic
peptid
inhibit
rsv
earli
step
replic
cycl
next
determin
whether
peptid
could
inhibit
celltocel
spread
rsv
infect
use
recombin
rsv
rgrsv
express
gene
green
fluoresc
protein
locat
first
posit
rsv
gene
order
ad
cell
hour
rsv
adsorpt
evalu
monolay
fluoresc
microscopi
hour
infect
fig
inhibit
celltocel
spread
syncytia
format
rgrsvinfect
cell
treat
peptid
compar
untreat
infect
cell
number
infect
cell
increas
hour
infect
indic
complet
one
round
viral
replic
product
new
virion
infect
new
cell
hour
therefor
addit
seem
prevent
subsequ
spread
cellfre
viru
cell
well
prevent
syncytium
format
data
also
support
possibl
block
earli
step
viral
life
cycl
next
test
whether
peptid
inhibit
rsv
revers
dialyz
peptid
peptid
suspens
overnight
ad
cell
monolay
rsv
plaqu
well
treat
dialyz
peptid
suspens
contrast
presenc
mani
plaqu
well
treat
dialyz
peptid
suspens
data
shown
indic
peptid
bind
high
avid
rsv
f
celltocel
fusion
assay
determin
whether
peptid
biolog
effect
celltocel
fusion
induc
rsv
f
use
assay
base
cytoplasm
activ
report
gene
rsv
envelop
protein
f
g
sh
shown
assay
optim
celltocel
assay
modif
one
cell
popul
infect
recombin
vaccinia
viru
transfect
three
separ
plasmid
contain
rsv
f
g
sh
gene
cell
popul
infect
recombin
vaccinia
viru
express
two
cell
popul
mix
either
treat
peptid
left
untreat
cell
fusion
measur
situ
assay
use
xgal
stain
cell
fig
quantit
colorimetr
lysat
assay
fig
well
treat
peptid
show
blue
fuse
cell
fig
contrast
well
treat
peptid
fig
untreat
well
fig
situ
assay
correl
quantit
colorimetr
assay
treat
untreat
well
fig
control
well
contain
one
popul
cell
express
g
sh
anoth
popul
cell
infect
vaccinia
viru
express
show
activ
data
shown
data
show
celltocel
fusion
induc
rsv
f
block
peptid
indic
celltocel
spread
viru
syncytium
format
may
requir
bind
f
rhoa
rhoa
peptid
inhibit
f
interact
determin
whether
peptid
interfer
interact
f
rhoa
competit
enzymelink
immunosorb
assay
elisa
fig
coat
well
ng
purifi
f
block
ad
ng
rhoa
increas
concentr
peptid
rang
ngml
detect
bound
rhoa
monoclon
antibodi
rhoa
use
rhoa
without
peptid
posit
control
neg
control
use
protein
instead
rhoa
respect
correl
concentr
peptid
inhibit
rhoa
interact
f
result
concentr
similar
data
untreat
posit
control
wherea
result
bind
f
similar
background
valu
data
indic
biolog
effect
demonstr
peptid
cell
cultur
vivo
base
inhibit
interact
rhoa
viral
fusion
protein
next
determin
whether
bind
peptid
f
revers
nonrevers
elisa
ad
rhoa
protein
hour
allow
peptid
bind
f
protein
incub
hour
detect
rhoa
use
monoclon
antibodi
rhoa
bind
rhoa
f
data
shown
thu
peptid
bind
f
high
avid
rhoa
peptid
block
infect
anim
model
rsv
determin
whether
rhoa
peptid
would
alter
cours
infect
vivo
infect
balbc
mice
intranas
ml
contain
plaqueform
unit
pfu
live
rsv
use
wellestablish
administ
peptid
peptid
pb
intranas
immedi
hour
day
rsv
infect
mice
treat
peptid
immedi
hour
viru
infect
discern
ill
weight
loss
wherea
pbstreat
control
mice
experienc
typic
ill
pattern
fig
peak
weight
loss
baselin
mice
treat
peptid
day
viru
infect
ill
weight
loss
similar
mice
treat
pb
plaqu
assay
lung
day
rsv
challeng
show
peptid
treatment
immedi
hour
viru
infect
reduc
rsv
titer
compar
rsv
titer
lung
control
mice
treat
pb
peptid
fig
data
indic
diminish
ill
mice
treat
peptid
rsv
infect
could
due
inhibit
viru
replic
peptid
rhoa
peptid
inhibit
infect
amino
terminu
rsv
fusion
glycoprotein
similar
structur
hydrophob
envelop
next
determin
whether
peptid
could
block
infect
influenza
viru
herp
simplex
viru
type
vaccinia
viru
coronaviru
mous
hepat
viru
strain
syncytium
format
inhibit
cell
fig
peptid
howev
infect
influenza
viru
herp
simplex
viru
type
vaccinia
viru
coronaviru
inhibit
peptid
data
shown
treatment
peptid
effect
syncytium
format
fig
data
indic
common
mechan
virusinduc
syncytium
format
involv
rhoa
may
share
two
paramyxovirus
also
indic
although
common
motif
present
amino
terminu
fusion
protein
mani
envelop
virus
host
cell
compon
involv
syncytium
format
may
differ
viru
famili
hallmark
rsv
cytopath
effect
cell
cultur
extens
syncytium
format
fusion
glycoprotein
f
mediat
virusinduc
fusion
neutral
ph
membran
fusion
depend
densiti
fusion
protein
infect
cell
cellular
protein
contribut
paramyxovirusinduc
syncytia
format
identifi
howev
lipid
composit
properti
target
cell
membran
influenc
abil
viru
produc
host
protein
rhoa
shown
bind
viral
fusion
glycoprotein
facilit
syncytium
shown
inhibit
rsv
syncytium
format
rhoaderiv
peptid
rsv
f
bind
domain
inhibit
indic
two
virus
paramyxovirida
famili
may
use
host
cell
protein
bind
site
protein
process
induc
celltocel
fusion
strengthen
concept
conserv
function
structur
featur
paramyxoviru
fusion
protein
role
rhoa
virusinduc
fusion
yet
defin
might
includ
direct
effect
indirect
effect
signal
event
cellular
cytoskelet
organ
cell
shape
cell
motil
f
protein
interact
rhoa
might
also
involv
aspect
viru
replic
includ
assembl
filament
format
bud
peptid
deriv
heptad
repeat
region
viral
fusion
inhibit
syncytium
format
homolog
viru
bind
heptad
repeat
interf
fusion
protein
structur
inhibitori
peptid
describ
differ
natur
shown
peptid
deriv
cellular
protein
sequenc
homolog
viral
fusion
protein
specif
inhibit
virusinduc
syncytium
format
possibl
viru
entri
yeast
twohybrid
assay
rhoa
shown
bind
rsv
f
construct
express
heptad
repeat
region
fusion
protein
construct
encod
f
residu
ref
indic
mechan
fusion
inhibit
rhoaderiv
peptid
differ
peptid
interf
heptad
repeat
interact
complet
inhibit
rsv
infect
peptid
ad
rsv
adsorpt
cell
fig
immedi
rgrsv
infect
fig
indic
peptid
interfer
virusmedi
fusion
event
immunohistochem
stain
rsv
f
fig
show
express
rsv
f
cell
analysi
viru
growth
curv
indic
viru
yield
data
shown
peptid
inhibit
green
fluoresc
protein
express
rgrsvinfect
cell
indic
peptid
interf
earli
step
viru
replic
pathway
possibl
entri
could
true
infect
inhibitori
effect
peptid
specif
aminoacid
sequenc
synthet
peptid
peptid
analog
amino
acid
content
random
sequenc
inhibit
rsvinduc
syncytium
format
data
shown
also
indic
inhibitori
effect
peptid
base
hydrophob
charg
role
rhoa
celltocel
fusion
support
syncytiuminhibit
effect
peptid
rsvfree
celltocel
fusion
assay
fig
membran
fusion
involv
mix
membran
lipid
layer
result
mix
aqueou
content
donor
recipi
cell
fusion
assay
quantit
report
gene
activ
demonstr
content
mix
potenti
rsv
f
protein
presenc
absenc
peptid
celltocel
fusion
inhibit
peptid
peptid
inhibit
content
mix
prevent
celltocel
fusion
result
consist
data
rgrsvinfect
cell
presenc
rhoa
peptid
fig
peptid
inhibit
fusion
also
virusinduc
celltocel
fusion
data
competit
elisa
strongli
indic
biolog
effect
peptid
base
interfer
interact
rhoa
viral
fusion
protein
high
avid
bind
peptid
f
support
prior
analysi
rsv
interact
biomolecular
interact
analysi
base
surfac
plasmon
reson
observ
also
support
data
obtain
dialysi
experi
peptid
irrevers
prevent
rsvinduc
syncytium
format
despit
overnight
dialysi
blockad
rsv
syncytium
format
peptid
fig
respect
indic
mechan
virusinduc
membran
fusion
similar
virus
provid
addit
evid
conserv
structur
function
featur
fusion
protein
rsv
indic
sequenc
rais
possibl
design
singl
antivir
agent
paramyxovirusinduc
diseas
exampl
rhoaderiv
peptid
relat
peptidomimet
compound
small
molecul
capabl
interf
rhoafus
protein
interact
could
potenti
clinic
effect
rsv
treatment
similar
peptid
deriv
ctermin
heptad
repeat
inhibitori
effect
vivo
viru
replic
potenti
diminish
ill
mous
model
rsv
fig
indic
earli
treatment
rhoaderiv
peptid
therapeut
potenti
rsv
infect
particularli
giant
cell
pneumonia
seen
patient
bone
marrow
transplant
lung
transplant
sever
combin
immunodefici
although
peptid
treatment
immedi
hour
rsv
infect
prevent
ill
mice
treatment
day
rsv
infect
effect
ill
data
shown
consist
antivir
approach
reflect
fact
ill
mediat
tcell
respons
direct
virusinduc
cytopatholog
antivir
therapi
must
given
earli
combin
immunomodul
conclus
rhoaderiv
peptid
shown
inhibit
rsv
infect
syncytium
format
also
block
celltocellfus
viru
fusion
glycoprotein
f
induc
celltocel
fusion
assay
given
immedi
infect
hour
rsv
infect
peptid
reduc
rsv
titer
prevent
ill
mice
exploit
interact
rhoa
f
protein
may
also
use
design
peptidomimet
lowmolecularweight
antivir
drug
strain
rsv
provid
r
chanock
nation
institut
health
bethesda
maryland
rgrsv
provid
peepl
rush
medic
colleg
chicago
illinoi
p
collin
nation
institut
health
bethesda
maryland
wildtyp
parainfluenza
viru
type
influenza
viru
herp
simplex
viru
type
coronaviru
mous
hepat
viru
strain
strain
provid
b
murphi
p
wright
p
spearman
denison
respect
rsv
stock
prepar
cell
maintain
eagl
minim
essenti
media
emem
supplement
glutamin
gentamicin
penicillin
g
fetal
bovin
serum
fb
peptid
synthes
research
genet
huntsvil
alabama
free
acid
approxim
puriti
desalt
lyophil
form
major
speci
prepar
calcul
molecular
weight
desir
peptid
base
mass
spectrometri
aminoacid
sequenc
peptid
drlrplsypdtdvilmcf
tdvilmcfsidspdsleni
dspdslenipekwtpevkh
scrambl
ddmsviselictspldfin
peptid
resuspend
deioniz
distil
water
assay
peptid
incub
h
ice
pfuml
rsv
peptid
concentr
media
suspens
ad
cell
plate
defin
concentr
peptid
rang
use
plate
fix
methanol
rsvspecif
immunoperoxidas
stain
rsv
plaqu
count
well
experi
use
rgrsv
cell
well
plate
infect
rgrsv
stock
viru
peptid
ad
h
infect
h
infect
infect
cell
view
fluoresc
microscopi
cell
infect
rgrsv
without
peptid
use
control
test
whether
peptid
bind
rsv
revers
ml
media
contain
pfuml
rsv
peptid
suspens
incub
ice
h
rsv
without
peptid
use
control
cellulos
ester
membran
spectrum
medic
industri
houston
texa
molecular
weight
cutoff
use
dialyz
suspens
pb
overnight
overnight
dialysi
suspens
ad
cell
plate
plate
fix
stain
describ
rsv
plaqu
count
well
abil
peptid
inhibit
rsv
finduc
celltocel
fusion
assess
use
quantit
assay
base
cytoplasm
activ
report
gene
one
popul
cell
infect
recombin
vaccinia
viru
encod
polymeras
multipl
infect
pfu
per
cell
transfect
plasmid
encod
rsv
glycoprotein
f
g
sh
control
promot
gift
p
collin
nation
institut
health
bethesda
maryland
use
lipofectamin
life
technolog
h
transfect
cell
express
viral
envelop
protein
trypsin
suspend
mem
contain
fb
densiti
cell
per
ml
incub
overnight
cell
wash
suspend
optimem
life
technolog
concentr
cell
per
ml
second
popul
cell
infect
recombin
vaccinia
viru
express
control
promot
provid
ea
berger
nation
institut
health
bethesda
maryland
h
infect
cell
trypsin
final
suspend
concentr
cell
per
ml
cell
popul
express
viral
glycoprotein
treat
peptid
left
untreat
incub
min
two
cell
popul
mix
triplic
ad
cell
popul
tissu
cultur
plate
incub
h
cell
fusion
measur
quantit
colorimetr
lysat
assay
situ
assay
use
xgal
life
technolog
stain
cell
colorimetr
lysat
assay
volumevolum
ad
well
content
mix
pipet
activ
quantifi
ambient
temperatur
flatbottom
plate
mix
lysat
substrat
solut
mm
cprg
boehring
kcl
rate
substrat
hydrolysi
ambient
temperatur
monitor
measur
absorb
nm
spectrophotomet
quantiti
calcul
compar
hydrolysi
rate
sampl
obtain
standard
commerci
prepar
escherichia
coli
umg
boehring
level
express
nanogram
per
well
situ
assay
fix
solut
formaldehyd
glutaraldehyd
pb
ad
well
plate
incub
min
without
disturb
settl
cell
ml
medium
gentli
remov
replac
ml
stain
solut
mm
potassium
ferricyanid
mm
potassium
ferrocyanid
mm
magnesium
chlorid
mgml
xgal
freshli
dilut
mgml
stock
solut
dimethyl
formamid
plate
incub
overnight
allow
complet
stain
bluestain
syncytia
view
invert
phasecontrast
microscop
immunoaffinitypurifi
rsv
f
protein
gift
biolog
west
henrietta
new
york
dilut
concentr
ngml
carbonatebicarbon
buffer
ph
suspens
contain
ng
f
protein
appli
well
immulon
ii
plate
nunc
roskild
denmark
block
accomplish
overnight
nonfat
dri
milk
bsa
block
buffer
contain
ng
rhoa
anoth
rho
famili
gtpase
calbiochem
la
jolla
california
increas
concentr
either
peptid
rang
ngml
ad
separ
incub
overnight
rhoa
ad
without
peptid
use
posit
control
neg
control
protein
use
instead
rhoa
respect
monoclon
antibodi
rhoa
dilut
santa
cruz
biotech
santa
cruz
california
block
buffer
ad
well
wash
pb
tween
h
plate
wash
goat
antibodi
mous
igg
conjug
horseradish
peroxidas
dilut
ad
wash
substrat
sigma
ad
absorb
measur
nm
use
microtit
plate
reader
dynatech
chantilli
virginia
pathogenfre
balbc
mice
obtain
charl
river
laboratori
raleigh
north
carolina
hous
barrier
facil
mice
anesthet
intranas
infect
ml
contain
pfu
live
rsv
immedi
h
rsv
infect
peptid
pb
given
intranas
lung
obtain
five
mice
group
day
infect
rsvinfect
mice
treat
peptid
pb
immedi
h
rsv
infect
five
rsvinfect
mice
group
weigh
infect
ill
grade
daili
observ
blind
treatment
statu
mice
clinic
featur
ill
score
appar
ill
slightli
ruffl
fur
ruffl
fur
activ
ruffl
fur
inact
ruffl
inact
hunch
postur
gaunt
dead
four
day
rsv
infect
mice
kill
narcosi
cervic
disloc
lung
remov
place
emem
fb
quickli
frozen
bath
ice
rsv
titer
lung
measur
standard
plaqu
use
monolay
confluent
lung
thaw
quickli
ground
mortar
pestl
serial
dilut
lung
supernat
use
infect
monolay
triplic
cultur
grown
methylcellulos
emem
fb
cell
formalinfix
infect
stain
hematoxylin
eosin
plaqu
count
use
dissect
microscop
data
present
geometr
mean
pfu
per
gram
lung
tissu
standard
deviat
sd
dilut
produc
five
plaqu
per
well
peptid
concentr
incub
stock
h
ice
suspens
ad
cell
plate
plaqu
view
phase
contrast
microscopi
